Black Diamond Company Insiders
| BDTX Stock | USD 1.69 0.01 0.60% |
Black Diamond employs about 24 people. The company is managed by 10 executives with a total tenure of roughly 56 years, averaging almost 5.0 years of service per executive, having 2.4 employees per reported executive. Break down of Black Diamond's management performance can provide insight into the company performance.
Black |
Black Diamond Management Team Effectiveness
The company has return on total asset (ROA) of (0.3371) % which means that it has lost $0.3371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6967) %, meaning that it created substantial loss on money invested by shareholders. Black Diamond's management efficiency ratios could be used to measure how well Black Diamond manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.6 in 2025. Return On Capital Employed is likely to drop to -0.81 in 2025. At this time, Black Diamond's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.7 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 100.8 M in 2025.Common Stock Shares Outstanding is likely to drop to about 36 M in 2025. Net Loss is likely to drop to about (86.2 M) in 2025
Black Diamond Workforce Comparison
Black Diamond Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,641. Black Diamond claims roughly 24.0 in number of employees contributing just under 2% to equities under Health Care industry.
Black Diamond Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Black Diamond insiders, such as employees or executives, is commonly permitted as long as it does not rely on Black Diamond's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Black Diamond insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Behbahani Ali over two weeks ago Acquisition by Behbahani Ali of 1000000 shares of Black Diamond at 5.0 subject to Rule 16b-3 | ||
Hatzis-schoch Brent over a month ago Acquisition by Hatzis-schoch Brent of 75000 shares of Black Diamond subject to Rule 16b-3 | ||
Campbell Shannon over three months ago Acquisition by Campbell Shannon of 4500 shares of Black Diamond at 2.5 subject to Rule 16b-3 | ||
Hatzis-schoch Brent over three months ago Acquisition by Hatzis-schoch Brent of 200000 shares of Black Diamond at 4.86 subject to Rule 16b-3 | ||
Raman Prakash over six months ago Acquisition by Raman Prakash of 2694 shares of Black Diamond at 4.78 subject to Rule 16b-3 | ||
Erika Jones over six months ago Acquisition by Erika Jones of 100000 shares of Black Diamond at 4.86 subject to Rule 16b-3 | ||
Raman Prakash over six months ago Insider Trading | ||
Versant Venture Capital Vi, L.p. over six months ago Disposition of 221600 shares by Versant Venture Capital Vi, L.p. of Black Diamond at 6.3202 subject to Rule 16b-3 |
Black Diamond Notable Stakeholders
A Black Diamond stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Black Diamond often face trade-offs trying to please all of them. Black Diamond's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Black Diamond's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Melanie Morrison | Sr Operations | Profile | |
| Fang PharmD | Principal CFO | Profile | |
| Christopher Roberts | Advisor | Profile | |
| Elizabeth Montgomery | Chief Officer | Profile | |
| TaiAn Lin | VP Biology | Profile | |
| JD Esq | COO Counsel | Profile | |
| Elizabeth Buck | CoFounder Officer | Profile | |
| Sergey MD | Chief Officer | Profile | |
| David Epstein | President, CoFounder | Profile | |
| Erika Jones | Corporate Finance | Profile |
About Black Diamond Management Performance
The success or failure of an entity such as Black Diamond Therap often depends on how effective the management is. Black Diamond management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Black management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Black management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.57) | (0.60) | |
| Return On Capital Employed | (0.77) | (0.81) | |
| Return On Assets | (0.57) | (0.60) | |
| Return On Equity | (0.84) | (0.79) |
Please note, the imprecision that can be found in Black Diamond's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Black Diamond Therapeutics. Check Black Diamond's Beneish M Score to see the likelihood of Black Diamond's management manipulating its earnings.
Black Diamond Workforce Analysis
Traditionally, organizations such as Black Diamond use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Black Diamond within its industry.Black Diamond Manpower Efficiency
Return on Black Diamond Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2.9M | |
| Net Loss Per Executive | 7M | |
| Working Capital Per Employee | 3.4M | |
| Working Capital Per Executive | 8.1M |
Additional Tools for Black Stock Analysis
When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.